Stock listing
KALA Stock Price, News, Filings & Events — Kala Bio, Inc.
Selected listing: KALA · NASDAQ · USD · US
This page tracks Kala Bio, Inc.'s KALA:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following KALA:NASDAQ. KALA:NASDAQ is the stock-level entry point for investors researching Kala Bio, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Kala Bio, Inc. is a public company listed under the ticker KALA, operating in the American market. The company currently has a market capitalization of approximately $14.4 million. Kala Bio focuses on developing innovative therapies, although specific product details and financial performance are not provided.
- Ticker
- KALA:NASDAQ
- Asset type
- Stock
- Market cap
- $15.9M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
Kala Bio, Inc. KALA:NASDAQ stock context
This page tracks Kala Bio, Inc.'s KALA:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following KALA:NASDAQ. KALA:NASDAQ is the stock-level entry point for investors researching Kala Bio, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Kala Bio, Inc. is a public company listed under the ticker KALA, operating in the American market. The company currently has a market capitalization of approximately $14.4 million. Kala Bio focuses on developing innovative therapies, although specific product details and financial performance are not provided.
Latest news from Kala Bio, Inc.
Kala Bio and Virotek Announce Letter of Intent to Establish an Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing ...
September 1, 2026
Kailera Therapeutics Appoints Kathleen Tregoning as Chief Corporate Affairs Officer
June 29, 2026
KALA BIO Announces Reverse Stock Split
May 7, 2026
Aterian, Inc. Announces Definitive Agreement for the Sale of its Marquee Brand Portfolio for $18 Million Subject to Adjustments
April 28, 2026
Kala Bio Celebrates Trump Executive Order as Game-Changer for Psychedelic Medicine
April 21, 2026
Kala Bio, Inc. earnings calls
KALA BIO, Inc. (KALA) Q2 2022 Earnings Call
August 11, 2022 · Replay with transcript and chapters
KALA BIO, Inc. (KALA) Q1 2022 Earnings Call
May 16, 2022 · Replay with transcript and chapters
KALA BIO, Inc. (KALA) Q4 2021 Earnings Call
March 29, 2022 · Replay with transcript and chapters
KALA BIO, Inc. (KALA) Q3 2021 Earnings Call
November 15, 2021 · Replay with transcript and chapters
KALA BIO, Inc. (KALA) Q2 2021 Earnings Call
August 5, 2021 · Replay with transcript and chapters
KALA BIO, Inc. (KALA) Q1 2021 Earnings Call
May 5, 2021 · Replay with transcript and chapters
Research Kala Bio, Inc.
Kala Bio, Inc. investor report
Review AI stock analysis and investor report context for KALA:NASDAQ.
Kala Bio, Inc. company profile
View the public company page for Kala Bio, Inc. on 6ix.
Kala Bio, Inc. news
Read company news and market updates connected to Kala Bio, Inc..
Kala Bio, Inc. investor events
Find investor webinars, events, and replay context for Kala Bio, Inc..
Alternate listings
27F0:GETTEX
DE · EUR
Alternate listing for Kala Bio, Inc.; the primary context on this page is KALA:NASDAQ.
A3DWPS:LSX
DE · EUR
Alternate listing for Kala Bio, Inc.; the primary context on this page is KALA:NASDAQ.
KALA:BOATS
US · USD
Alternate listing for Kala Bio, Inc.; the primary context on this page is KALA:NASDAQ.
0JQ2:LSE
GB · USD
Alternate listing for Kala Bio, Inc.; the primary context on this page is KALA:NASDAQ.
A3DWPS:LS
DE · EUR
Alternate listing for Kala Bio, Inc.; the primary context on this page is KALA:NASDAQ.
27F:TRADEGATE
DE · EUR
Alternate listing for Kala Bio, Inc.; the primary context on this page is KALA:NASDAQ.
27F:GETTEX
DE · EUR
Alternate listing for Kala Bio, Inc.; the primary context on this page is KALA:NASDAQ.
27F:MUN
DE · EUR
Alternate listing for Kala Bio, Inc.; the primary context on this page is KALA:NASDAQ.
A4243T:LSX
DE · EUR
Alternate listing for Kala Bio, Inc.; the primary context on this page is KALA:NASDAQ.
27F:FWB
DE · EUR
Alternate listing for Kala Bio, Inc.; the primary context on this page is KALA:NASDAQ.
A4243T:LS
DE · EUR
Alternate listing for Kala Bio, Inc.; the primary context on this page is KALA:NASDAQ.